SCHEMBL3901168

SCHEMBL3901168

CN(Cc1ccc(Cl)cc1Cl)C(=O)c1ccc(Cl)cc1NS(=O)(=O)C1=CC=CN2SNC=C12

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
CCKBR P32239 4/20 0.40
CCKAR P32238 3/20 0.36
CCR2 P41597 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
GCGR P47871 1/20 0.32
ALDH1A1 P00352 2/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
PCTP Q9UKL6 1/20 0.30
STARD10 Q9Y365 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
APOBEC3G Q9HC16 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3911053 0.95 CRHBP (0.40) CRHBPCRHR2CCKBRCCKARMEN1
SCHEMBL3902440 0.95 CCKBR (0.38) CRHBPCRHR2CCKBRCCKARCCR2
SCHEMBL3905799 0.95 CRHBP (0.38) CRHBPCRHR2CCKBRCCKARMEN1
SCHEMBL3905812 0.95 CRHBP (0.38) CRHBPCRHR2CCKBRCCKARCCR2
SCHEMBL3906684 0.94 CRHBP (0.39) CRHBPCRHR2CCKBRCCKARMEN1
SCHEMBL3896931 0.94 CRHBP (0.40) CRHBPCRHR2CCKBRMEN1KMT2A
SCHEMBL3906317 0.91 CCR2 (0.39) CRHBPCRHR2CCKBRCCKARCCR2
SCHEMBL3902511 0.90 CCKBR (0.46) CCKBRCCKARCCR2KMT2AALDH1A1
SCHEMBL3902490 0.89 CCKBR (0.53) CCKBRCCKARKMT2AALDH1A1GAA
SCHEMBL3902433 0.88 CRHBP (0.36) CRHBPCRHR2CCKBRCCR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US claimed
US-7550492-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2009-06-23 US disclosed
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-29 US disclosed
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US disclosed
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA, N.V. (BE) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS CCKBR, CCKAR, GIPR CRHBP 784/4885CRHR2 60/4885CCKBR 1/4885
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds CCKBR, CCKAR, BRSK2 CRHBP 956/4885CRHR2 61/4885CCKBR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.